Get startedLog in
    Picture of Suven Life Sciences logo

    SUVEN — Suven Life Sciences News Story

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    All News

    Brief: Suven Life Sciences To Present Positive Results From Phase-2A Proof-Of-Concept Study Of Ropanicant

    Picture of Suven Life Sciences logoSuven Life Sciences
    03/10/2024 07:54
    Oct 3 (Reuters) - Suven Life Sciences Ltd  SUVP.NS :
    * TO PRESENT POSITIVE RESULTS FROM PHASE-2A PROOF-OF-CONCEPT
STUDY
OF ROPANICANT
    * TO ADVANCE ROPANICANT INTO DOUBLE-BLIND,
PLACEBO-CONTROLLED
PHASE-2B STUDY

Source text for Eikon:  ID:nBSE6Btb99 
Further company coverage:  SUVP.NS 

 ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on Suven Life Sciences

    See all news